Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FBCP4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,213
Award facts
- Contract value 100% obligated
- $15,213.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $15,213.27, awards AmerisourceBergen Drug Corp the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with the Defense Logistics Agency (DLA). The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills pharmaceutical and medical supply needs across multiple therapeutic domains for the Department of Defense and military healthcare systems. The DLA Troop Support Medical IDC enables the company to deliver a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support Defense Health Agency operations and other government healthcare customers worldwide. This award demonstrates the contractor's continued capability to meet federal procurement requirements through competitive processes and supports ongoing military pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FBCP4?
SPE2DB25FBCP4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FBCP4 worth?
The government has obligated $15,213 on SPE2DB25FBCP4.
Is contract SPE2DB25FBCP4 an order under another contract?
Yes. SPE2DB25FBCP4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBCP4 competed?
The extent of competition for SPE2DB25FBCP4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award